高级检索
徐艺, 于锋, 刘云. 非编码RNA在肺动脉高压中的作用[J]. 中国药科大学学报, 2019, 50(1): 107-112. DOI: 10.11665/j.issn.1000-5048.20190115
引用本文: 徐艺, 于锋, 刘云. 非编码RNA在肺动脉高压中的作用[J]. 中国药科大学学报, 2019, 50(1): 107-112. DOI: 10.11665/j.issn.1000-5048.20190115
XU Yi, YU Feng, LIU Yun. Role of non-coding RNA in pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2019, 50(1): 107-112. DOI: 10.11665/j.issn.1000-5048.20190115
Citation: XU Yi, YU Feng, LIU Yun. Role of non-coding RNA in pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2019, 50(1): 107-112. DOI: 10.11665/j.issn.1000-5048.20190115

非编码RNA在肺动脉高压中的作用

Role of non-coding RNA in pulmonary arterial hypertension

  • 摘要: 非编码RNA(non-coding RNA,ncRNA)是一类具有多种功能而不翻译蛋白质的RNA。它包括microRNA、lncRNA、ceRNA等。ncRNA主要通过表观遗传学在基因转录过程中对其表达进行调控。近年大量研究发现ncRNA可以引起多种疾病,如心血管疾病、肿瘤、肺动脉高压(PAH)等。本文对ncRNA在PAH形成过程中的作用相关研究进展作综述,以期为肺动脉高压的治疗提供理论依据。

     

    Abstract: Non-coding RNA(ncRNA), a group of RNAs including microRNA, lncRNA, ceRNA, etc. , has multiple functions without protein-coding. It can regulate gene expression through epigenetics by various aspects such as transcription and post-transcription regulation. Recently, a large number of studies have found that ncRNA can cause a variety of diseases, such as cardiovascular disease, cancer, pulmonary arterial hypertension(PAH)and so on. This paper reviews the research progress on the role of ncRNA in PAH formation to provide theoretical foundation for the treatment of PAH.

     

/

返回文章
返回